Metropolitan Life Insurance Company (MetLife)’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,181	Closed	-$73.4K	–	2365
2023 Q4	$73.4K	Buy	+1,181	New	+$29.4K	﹤0.01%	1243

Metropolitan Life Insurance Company (MetLife)'s RYZB Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,181 shares — an estimated $73.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $73.4K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,181 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $73.4K.
Metropolitan Life Insurance Company (MetLife) first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Metropolitan Life Insurance Company (MetLife)'s RayzeBio, Inc. Common Stock position peaked at $73.4K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.